Studying Cognition in SPG4

NCT03104088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-08-28

No results posted yet for this study

Summary

Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.

Conditions

Interventions

DIAGNOSTIC_TEST

CANTAB

CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)

DIAGNOSTIC_TEST

MOCA

Montreal cognitive assessment (MOCA) in German

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Ludger Schöls, Prof. Dr. · University Hospital Tübingen, Center for Neurology

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2017-12-24
Completion
2017-12-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03104088 on ClinicalTrials.gov